Type 2 Diabetes – Discover Pharma

Welcome to Discover Pharma! Today is : October 24, 2026

Type 2 Diabetes

Medical devices
Morphic Medical appoints Jane Wright as chief financial officer during European rollout of Reset
Appointment strengthens leadership team as company expands access to its [...]

September 15, 2025
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events
Ciloa lands €6.5 million (£5.7 million) government backing to develop novel obesity and diabetes bio-drug
Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]

May 5, 2026
Clinical & Regulatory
Orforglipron: Lilly’s first oral GLP 1 pill cuts A1C by up to 1.6% and trims 16 lbs in Phase 3 trial
May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK